GENETIC ENGINEERING AND BIOTERRORISM “In warfare there are no constant conditions. He, who can modify his tactics in relation to his opponent, will succeed and win. “ Sun Tzu The biological weapons...

Last week, Gaithersburg, MD based biopharmaceutical company, Emergent BioSolutions Inc. announced the signing of a nearly $1 billion contract with the Centers for Disease Control and Prevention (CDC)...

Scientists are gaining an insider’s look behind the notorious infectivity of Francisella tularensis. This bacterium is an equal opportunity pathogen. It causes the disease tularemia in humans, rabbits...

An Ebola vaccine will take the next critical steps in development under a $24.75 million contract through May 2020 between the U.S. Department of Health and Human Services’ Office of the Assistant...

Professor at Laboure College in Milton, MA and biodefense and bioterrorism researcher, Lawrence Roberge PhD joined me on the Outbreak News This Week Radio Show to discuss a myriad of topics related...

An anthrax vaccine that may be effective in as few as two doses is moving forward in development with the assistance of the U.S. Department of Health and Human Services’ (HHS) Office of the Assistant...

The first potential antidote to treat the life-threatening effects of chlorine inhalation, a potential terrorism threat, will advance in development under a contract between the U.S. Department of Health...

In July, California Democratic Senator Barbara Boxer promoted a public health emergency funding bill to help health officials with responding to epidemics and other public health emergencies. Today, Sen...

Earlier this week, we reported on the arrests of of two terror suspects in Kenya, part of an extremist cell of medics loyal to ISIS who had plans of an anthrax attack in the country. This followed other...

Bioterrorism and biodefense is a topic that seems to sit under the radar; however, it is there and always remains a concern. There is a long history of intentional release or dissemination of biological...